Stock page
SynCardia Systems Inc (TAHT)
SynCardia Systems Inc was incorporated in Delaware in August 2001. The Company is a medical technology company. It is engaged in developing, manufacturing and commercializing SynCardia temporary Total Artificial Heart, or TAH-t, an implantable system designed to assume the full function of a failed human heart in patients suffering from heart failure. Its operations are carried out in United States, Europe and other parts of the world. Its manufacturing facilities are located in Tucson, Arizona. Its products include SynCardia 70cc TAH-t and SynCardia 50cc TAH-t. The Company's customers include medical centers operating heart transplant and MCS programs. It faces competition from medical device companies & medical device divisions of health care companies & pharmaceutical companies. As of June 2015, the Company owns three issued U.S. patents and one issued foreign patent relating to its drivers, & owns one pending foreign patent application relating to its drivers. The Company is subject to change in governmental laws and regulations.
Quote snapshot
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|